Literature DB >> 25976493

Proton beam therapy: the next disruptive innovation in healthcare?

Samuel Swisher-McClure1, Stephen M Hahn1, Justin Bekelman1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25976493      PMCID： PMC4470251          DOI： 10.1136/postgradmedj-2014-132935

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  14 in total

Review 1.  Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials.

Authors:  Gordon C S Smith; Jill P Pell
Journal:  BMJ       Date:  2003-12-20

2.  Position statement on ethics, equipoise and research on charged particle radiation therapy.

Authors:  Mark Sheehan; Claire Timlin; Ken Peach; Ariella Binik; Wilson Puthenparampil; Mark Lodge; Sean Kehoe; Michael Brada; Neil Burnet; Steve Clarke; Adrian Crellin; Michael Dunn; Piero Fossati; Steve Harris; Michael Hocken; Tony Hope; Jonathan Ives; Tadashi Kamada; Alex John London; Robert Miller; Michael Parker; Madelon Pijls-Johannesma; Julian Savulescu; Susan Short; Loane Skene; Hirohiko Tsujii; Jeffrey Tuan; Charles Weijer
Journal:  J Med Ethics       Date:  2013-09-17       Impact factor: 2.903

3.  Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.

Authors:  Roshan V Sethi; Helen A Shih; Beow Y Yeap; Kent W Mouw; Robert Petersen; David Y Kim; John E Munzenrider; Eric Grabowski; Carlos Rodriguez-Galindo; Torunn I Yock; Nancy J Tarbell; Karen J Marcus; Shizuo Mukai; Shannon M MacDonald
Journal:  Cancer       Date:  2013-10-02       Impact factor: 6.860

4.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

5.  Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients.

Authors:  L Desjardins; L Lumbroso-Le Rouic; C Levy-Gabriel; R Dendale; S Delacroix; C Nauraye; M Estève; C Plancher; B Asselain
Journal:  Ophthalmic Res       Date:  2006-07-28       Impact factor: 2.892

6.  Repeated proton beam therapy for hepatocellular carcinoma.

Authors:  Takayuki Hashimoto; Koichi Tokuuye; Nobuyoshi Fukumitsu; Hiroshi Igaki; Masaharu Hata; Kenji Kagei; Shinji Sugahara; Kiyoshi Ohara; Yasushi Matsuzaki; Yasuyuki Akine
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-24       Impact factor: 7.038

7.  A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas; A M Lane; S Regan; W Li; H E Judge; J E Munzenrider; J M Seddon; K M Egan
Journal:  Arch Ophthalmol       Date:  2000-06

8.  Site-specific range uncertainties caused by dose calculation algorithms for proton therapy.

Authors:  J Schuemann; S Dowdell; C Grassberger; C H Min; H Paganetti
Journal:  Phys Med Biol       Date:  2014-07-03       Impact factor: 3.609

9.  Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.

Authors:  Herman Suit; Hanne Kooy; Alexei Trofimov; Jonathan Farr; John Munzenrider; Thomas DeLaney; Jay Loeffler; Benjamin Clasie; Sairos Safai; Harald Paganetti
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

10.  Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.

Authors:  W U Shipley; L J Verhey; J E Munzenrider; H D Suit; M M Urie; P L McManus; R H Young; J W Shipley; A L Zietman; P J Biggs
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-04-30       Impact factor: 7.038
View more
  1 in total

1.  Inequality in Accessibility of Proton Therapy for Cancers and Its Economic Determinants: A Cross-Sectional Study.

Authors:  Zhongying Xia; Junfeng Wang; Jiaxin Xia; Menglei Wang; Zhiqiang Cheng
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.